Stock Market Today, March: CytomX Surges on Positive Data
CytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
Which Offers More Control: Index Fund Or Target Date Retirement. Understand where you have more say over allocations and timing for retirement planning.
28,368 articlesCytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
When a EZCORP director unloads 10,000 shares, investors naturally wonder if it signals trouble or simply a routine di...
Two popular aerospace ETFs, XAR and ITA, offer different paths to exposure in a sector shaped by defense spending and...
As Switzerland heads to the polls on a population cap, the country’s biotech and food giants warn that limiting immig...
A new survey finds a notable share of senior executives view data collection and use as ethically troubling, foreshad...
A Midtown building collapse is being linked to contractor error in a 1,600-unit office-to-residential conversion, fue...
As markets react to CODI's Q1 2026 results, the codi 2026 earnings call offers a clear view of growth drivers, profit...
Broadcom is riding a powerful AI wave, with revenue in key AI-adjacent areas jumping. Yet the stock moved lower after...
Bitcoin is gaining traction as a potential safe haven as geopolitical tensions heighten market nerves and gold funds ...
SanDisk has enjoyed a dramatic rally, but traders are wrestling with whether the rally can run further as memory cycl...
Joby Aviation posted record Q4 2025 revenue driven by the Blade acquisition, but the stock remains volatile as cash b...
As markets wobble in June 2026, investors weigh the true liquidity of stocks. This report explains why stocks are sti...